In COVID-19 clinical update #94, Daniel Griffin reviews the FDA EUA for Paxlovid, test to stay in school, immunity after infection, variants and therapeutics, quarantine and isolation guidelines, Molnupiravir in non-hospitalized patients, and convalescent serum in outpatients.
Hosts: Daniel Griffin and Vincent Racaniello
Click arrow to play
Download TWiV 845 (58 MB .mp3, 48 min)
Subscribe (free): iTunes, Google Podcasts, RSS, email
Show notes at microbe.tv/twiv